Abstract
Some somatic illnesses such as peripheral tumours can present with psychiatric symptoms. Many of these are characterized by changes in biomarkers related to the inflammation or immune response. Here, we describe a multispectral imaging protocol that can be used to phenotype immune and other cell types through simultaneous imaging of multiple proteins in sections of peripheral solid tumours and other tissues. This approach can also be used to assess the spatial organization of these cells within the tissue.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T et al (2016) Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet 387:1672–1685
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders: (DSM-5). 5th edn. American Psychiatric Publishing, Arlington. (31 May 2013). ISBN-13: 978–0890425558
Guest FL, Guest PC, Martins-de-Souza D (2016) The emergence of point-of-care blood-based biomarker testing for psychiatric disorders: enabling personalized medicine. Biomark Med 10:431–443
Piccillo GA, Musco A, Manfrini S, Mondati E, Guastella T (2005) Two clinical cases of insulinoma misdiagnosed as psychiatric conditions. Acta Biomed 76:118–122
Ding Y, Wang S, Liu J, Yang Y, Liu Z, Li J, Zhang B et al (2010) Neuropsychiatric profiles of patients with insulinomas. Eur Neurol 63:48–51
Renca S, Santos G, Cerejeira J (2013) An insulinoma presenting with hypochondriac delusions and food refusal. Int Psychogeriatr 25:1909–1911
Winston KY, Dawrant J (2014) A rare case of hypoglycaemia due to insulinoma in an adolescent with acutely altered mental status. J Pediatr Endocrinol Metab 27:773–776
Yedinak CG, Fleseriu M (2014) Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study. Endocrine 46:585–593
Iglesias P, Bernal C, Díez JJ (2014) Curious cases: acromegaly and schizophrenia: an incidental association? Schizophr Bull 40:740–743
Dimopoulou C, Geraedts V, Stalla GK, Sievers C (2015) Neuropsychiatric and cardiometabolic comorbidities in patients with previously diagnosed Cushing’s disease: a longitudinal observational study. BMJ Open 5:e006134. doi:10.1136/bmjopen-2014-006134
Izmailov R, Guest PC, Bahn S, Schwarz E (2011) Algorithm development for diagnostic biomarker assays. Int Rev Neurobiol 101:279–298
Schwarz E, Guest PC, Steiner J, Bogerts B, Bahn S (2012) Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients. Transl Psychiatry 2:e82
Chan MK, Krebs MO, Cox D, Guest PC, Yolken RH, Rahmoune H et al (2015) Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset. Transl Psychiatry 5:e601. doi:10.1038/tp.2015.91
Freudenreich O, Brockman MA, Henderson DC, Evins AE, Fan X, Walsh JP et al (2010) Analysis of peripheral immune activation in schizophrenia using quantitative reverse-transcription polymerase chain reaction (RT-PCR). Psychiatry Res 176:99–102
Herberth M, Koethe D, Cheng TM, Krzyszton ND, Schoeffmann S, Guest PC et al (2011) Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients. Mol Psychiatry 16:848–859
Xu Y, Yao Shugart Y, Wang G, Cheng Z, Jin C, Zhang K et al (2016) Altered expression of mRNA profiles in blood of early-onset schizophrenia. Sci Rep 6:16767. doi:10.1038/srep16767
Wang L, Lockstone HE, Guest PC, Levin Y, Palotás A, Pietsch S et al (2010) Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia. J Proteome Res 9:521–527
Johansson AS, Owe-Larsson B, Hetta J, Lundkvist GB (2016) Altered circadian clock gene expression in patients with schizophrenia. Schizophr Res 174:17–23
Krishnamurthy D, Harris LW, Levin Y, Koutroukides TA, Rahmoune H, Pietsch S et al (2013) Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjects. World J Biol Psychiatry 14:478–489
Stelzhammer V, Alsaif M, Chan MK, Rahmoune H, Steeb H, Guest PC et al (2015) Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients. J Psychiatr Res 60:40–48
Muller N, Schwarz M (2006) Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotox Res 10:131–148
Lizano PL, Keshavan MS, Tandon N, Mathew IT, Mothi SS, Montrose DM et al (2016) Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: a preliminary study. Schizophr Res 170:115–122
Lai CY, Scarr E, Udawela M, Everall I, Chen WJ, Dean B (2016) Biomarkers in schizophrenia: a focus on blood based diagnostics and theranostics. World J Psychiatry 6:102–117
Medzhitov R, Shevach EM, Trinchieri G, Mellor AL, Munn DH, Gordon S et al (2011) Highlights of 10 years of immunology in Nature Reviews Immunology. Nat Rev Immunol 11:693–702
Mandy FF, Bergeron M, Minkus T (1997) Evolution of Leukocyte Immunophenotyping as Influenced by the HIV/AIDS Pandemic: a short history of the development of gating strategies for CD4^+ T-Cell enumeration. Cytometry 30:157–165
Loken MR (1990) Immunofluorescence techniques. In: Flow cytometry and sorting, 2nd edn. Wiley-Blackwell, New York, p 341–353. (21 Jun. 1990), ISBN-13: 978-0471562351
Zola H, Swart B, Banham A, Barry S, Beare A, Bensussan A et al (2007) CD molecules 2006--human cell differentiation molecules. J Immunol Methods 318:1–5
Lagouros E, Salomao D, Thorland E, Hodge DO, Vile R, Pulido JS (2009) Infiltrative T regulatory cells in enucleated uveal melanomas. Trans Am Ophthalmol Soc 107:223–228
Walling MA, Novak JA, Shepard JR (2009) Quantum dots for live cell and in vivo imaging. Int J Mol Sci 10:441–491
Akinfieva O, Nabiev I, Sukhanova A (2013) New directions in quantum dot-based cytometry detection of cancer serum markers and tumor cells. Crit Rev Oncol Hematol 86:1–14
Chen T, Srinivas C (2015) Group sparsity model for stain unmixing in brightfield multiplex immunohistochemistry images. Comput Med Imaging Graph 46(Pt 1):30–39
Buchwalow IB, Minin EA, Boecker W (2005) A multicolor fluorescence immunostaining technique for simultaneous antigen targeting. Acta Histochem 107:143–148
Tóth ZE, Mezey E (2007) Simultaneous visualization of multiple antigens with tyramide signal amplification using antibodies from the same species. J Histochem Cytochem 55:545–554
Stack EC, Wang C, Roman KA, Hoyt CC (2014) Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis. Methods 70:46–58
Mansfield JR (2014) Multispectral imaging: a review of its technical aspects and applications in anatomic pathology. Vet Pathol 51:185–210
Mansfield JR (2014) Imaging in cancer immunology:phenotyping immune cell subsets in situ in FFPE tissue sections. MLO Med Lab Obs 46:12–13
Zhou Y, Guang H, Pu H, Zhang J, Luo J (2016) Unmixing multiple adjacent fluorescent targets with multispectral excited fluorescence molecular tomography. Appl Optics 55:4843–4849
http://www.perkinelmer.co.uk/Content/LST_Software_Downloads/inFormUserManual.pdf
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Mansfield, J.R., Guest, P.C., Burks, J. (2017). Phenotyping Multiple Subsets of Immune Cells In Situ in Formalin-Fixed, Paraffin-Embedded Tissue Sections. In: Guest, P. (eds) Proteomic Methods in Neuropsychiatric Research. Advances in Experimental Medicine and Biology(), vol 974. Springer, Cham. https://doi.org/10.1007/978-3-319-52479-5_32
Download citation
DOI: https://doi.org/10.1007/978-3-319-52479-5_32
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52478-8
Online ISBN: 978-3-319-52479-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)